Results 191 to 200 of about 155,549 (248)
Pancreatic Cancer—Advances in the Last 50 Years
World Journal of Surgery, EarlyView.
S. George Barreto +5 more
wiley +1 more source
Abstract Background and Purpose Genomic profiling of patients for genetic variants that modify the effect of specific medications has many benefits, including the possibility of avoiding toxicities and ensuring an adequate effect of the medication. Our intention was to develop a comprehensive, high‐quality pharmacogenetic test panel for clinical use ...
Anna Gréen +5 more
wiley +1 more source
AI-driven breathomics for early detection of CFTR modulator resistance in cystic fibrosis. [PDF]
Khan MH, Tariq AU, Cheema WA, Fatima M.
europepmc +1 more source
Five Advances in Benign Pancreatic Surgery in the Last 50 Years
World Journal of Surgery, EarlyView.
Stephan B. Dreyer, Rowan W. Parks
wiley +1 more source
Identification of drug repurposing candidates for the treatment of polycystic kidney disease
Background and Purpose Autosomal dominant polycystic kidney disease (ADPKD) is a leading cause of end‐stage renal disease with limited treatment options. Drug repurposing offers a promising strategy to find effective treatments. Experimental Approach We identified birinapant, bardoxolone methyl and salicylic acid as repurposing candidates for ADPKD and
Alina Meyer +9 more
wiley +1 more source
Disparities in Access to Cystic Fibrosis Therapy Across Countries. [PDF]
Karadag B.
europepmc +1 more source
Utility of Fecal Elastase-1 in Estimating Exocrine Pancreatic Function in Cystic Fibrosis: A Scoping Review. [PDF]
Sankararaman S +3 more
europepmc +1 more source
Mental Health in Cystic Fibrosis in the Modulator Era: Epidemiology, Prognostic Significance, and Therapeutic Implications. [PDF]
Almulhem MM, Siraj RA.
europepmc +1 more source

